Navigation Links
ALIMTA Receives Positive Opinion From CHMP as Continuation Maintenance Therapy for Deadly Form of Lung Cancer
Date:9/26/2011

INDIANAPOLIS, Sept. 26, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the use of ALIMTA® (pemetrexed for injection) as continuation maintenance therapy in patients with advanced nonsquamous non-small cell lung cancer (NSCLC). Positive opinions from the CHMP are reviewed by the European Commission, which then decides on whether to approve the indication in Europe.

Maintenance therapy is a relatively new concept in lung cancer treatment in which patients start maintenance therapy immediately following their first-line treatments to try to maintain disease control.  No chemotherapy is currently approved in the "continuation maintenance" setting, in which one of the same medicines used in first-line treatment is continued as maintenance therapy. Currently approved maintenance therapies in lung cancer use different medicines in the first-line and maintenance phases of treatment.

"Lung cancer is one of the most difficult cancers to treat and new therapy options are much needed," said Allen Melemed, M.D., M.B.A., Alimta senior medical director with Lilly Oncology. "If approved, ALIMTA would be the first tailored treatment option based on efficacy that can potentially extend lives beginning in first-line treatment and continuing through maintenance in advanced nonsquamous non-small cell lung cancer."

The CHMP's opinion was based on results from PARAMOUNT, a randomized double-blind Phase III study presented in June 2011 at the American Society of Clinical Oncology Annual Meeting.(1) In this study, patients with advanced nonsquamous NSCLC received initial therapy with four cycles of ALIMTA plus cisplatin. Patients whose disease did not progress continued to the maintenance phase, where progression-free survi
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Lung Cancer Study Reveals Similar Outcomes for African-American and Caucasian Patients Treated With Alimta®
2. U.S. District Court Rules from Bench in Lillys Favor, Confirms Validity of Alimta Patent
3. OPAXIO(TM) Combined with Alimta(R) Well Tolerated in Dose-Ranging Study of Patients with Advanced Non-Small Cell Lung Cancer
4. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
5. Uptake Medical Receives CE Mark for InterVapor - Endoscopic Lung Volume Reduction for Treatment of Severe Emphysema - and Announces Positive Clinical Results
6. REMICADE® Receives FDA Approval as First Biologic Treatment for Pediatric Ulcerative Colitis
7. MiMedx Groups EpiFix® Receives American Podiatric Medical Association Seal of Approval
8. PLC Receives Two Additional U.S. Patents and First Japanese Patent For Its RenalGuard® Technology
9. MAQUET Cardiovascular Receives FDA 510(k) Clearance and CE Mark for Its New SENSATION PLUS™ Intra-Aortic Balloon Catheter
10. Mylans Matrix Receives Tentative FDA Approval Through PEPFAR for Novel "Co-Packaged" Version of HIV/AIDS Treatment
11. Echo Therapeutics Receives Registered Trademarks for Symphony® and Prelude®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... Dr. Michael Gabriel of a prominent Staten ... study, which shows how grief in pregnancy may cause obesity ... According to US News , "Unborn children ... others to grow up overweight or obese, even if that ... specific types of stress that caused obesity: "Children whose biological ...
(Date:7/24/2014)... 2014   AcelRx Pharmaceuticals, Inc.  (Nasdaq: ... development and commercialization of innovative therapies for the treatment ... date for Zalviso remains July 27, 2014.  ... stating the Food and Drug Administration (FDA) had approved ... no notification to the company from the FDA regarding ...
(Date:7/24/2014)... PARK, Kan. , July 24, 2014 /PRNewswire/ ... of two compounds that will be added to ... with Australian-based CIMTECH Pty Ltd, a biotechnology company. ... PAR 122 have shown promise in bone regeneration ... license to develop the compounds for the veterinary ...
Breaking Medicine Technology:Dr. Michael Gabriel of GPM Pediatrics, a Noted Staten Island Pediatrics Clinic, Comments on Study, Which Names Grief as a Cause of Obesity in Children 2AcelRx Pharmaceuticals Confirms July 27, 2014 PDUFA Date for Zalviso 2Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 2Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 3Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 4
(Date:7/25/2014)... July 25, 2014 Mahendra Trivedi and ... Online Workshop ‘Consciousness is Power’ on Saturday, July 26, ... to attend this life transforming event as they will ... higher level. Few days are left for the commencement ... Trivedi and Trivedi Masters™ Dahryn Trivedi (his wife) and ...
(Date:7/25/2014)... CMS recently has imposed a series ... inadequate access to prescription drugs. Agency audits are uncovering ... safety of beneficiaries in areas such as rejected pharmacy ... is taking quick and firm actions to halt them. ... “Avoiding Costly Part D Sanctions: Rx Access Strategies ...
(Date:7/25/2014)... 25, 2014 Yisrayl Hawkins, Pastor and Overseer ... on his blog explaining why so many prayers are going ... , In the article, Yisrayl gives many examples around ... the results. For example, in one case, in the small ... grounds to pray for rain; ironically, they received a massive ...
(Date:7/25/2014)... Yisrayl Hawkins, Pastor and Overseer of The House of Yahweh ... revealing to the whole world, including even the most devout ... in his new article. , Yisrayl says it all started ... by the Catholic Church. He says this plan included removing ... and replacing it with titles such as Lord and God. ...
(Date:7/25/2014)... According to the Hemorrhoid ... Vkool.com, this is a comprehensive guide that ... common types of hemorrhoids including:, ...     Young children with hemorrhoids , ...     Very large hemorrhoids and chronic hemorrhoids , ...
Breaking Medicine News(10 mins):Health News:Mahendra Trivedi to Host an Online Workshop ‘Consciousness is Power’ 2Health News:Mahendra Trivedi to Host an Online Workshop ‘Consciousness is Power’ 3Health News:Aug. 5 Webinar to Offer Strategies for Preventing Rx Access Issues and Avoiding Part D Sanctions 2Health News:Yisrayl Hawkins Says Prayers for Rain Result in Violent Hail Because Prayers Are Not Being Heard in New Post 2Health News:Yisrayl Hawkins Says Prayers for Rain Result in Violent Hail Because Prayers Are Not Being Heard in New Post 3Health News:Yisrayl Hawkins Says You Have Been Tricked Into Worshipping Satan in New Article 2Health News:Hemorrhoid No More Pdf Review Exposes Jessica Wright's Guide For Treating Hemorrhoids – Vkool.com 2Health News:Hemorrhoid No More Pdf Review Exposes Jessica Wright's Guide For Treating Hemorrhoids – Vkool.com 3
... SANTA MONICA, Calif., Oct. 8 Proposed,regulations that ... California stem cell research grants to for-profit organizations ... cures for California taxpayers,paying for the research, the ... "To ensure that the people who have ...
... Precise Surgical Laser Procedures, CAMBRIDGE, Mass., Oct. ... laser fibers for precision surgery, announced today,the launch ... procedures. The LightPath fiber features a fine ... safely conduct more precise procedures in Laryngology,Head & ...
... their own ... personal health info, PHILADELPHIA, Oct. ... largest organization of its,kind, will ask select groups of Americans to ... for,themselves, their children and ailing loved ones. At its 79th Annual,Convention ...
... like most, you eat worst at healthy restaurants., The ... treat themselves to higher-calorie side dishes, drinks or desserts ... no health claims, according to a series of new ... version of the Journal of Consumer Research , ...
... patients more likely to develop dementia, study finds ... people with Parkinson,s disease face up to a 73 ... new study that says genetics could be to blame. ... central nervous system, such as impaired motor skills and ...
... New research shows that selective serotonin reuptake inhibitors ... depression, may double the risk of gastrointestinal bleeding, according ... and colleagues. When the drugs are taken with aspirin ... than 600 percent higher. , Clinicians who prescribe these ...
Cached Medicine News:Health News:Revised California Stem Cell Research Rules Fail to Ensure Affordable Access to Cures, Consumers Warn 2Health News:OmniGuide Announces Launch of LightPath(TM) CO2 Laser Fiber 2Health News:AHIMA National Consumer Awareness Campaign Urges Patients to Assume Responsibility of Personal Health Records 2Health News:'Healthy' restaurants help make us fat, says a new Cornell study 2Health News:Parkinson's Linked to Risk of Alzheimer's 2Health News:Anti-depressant drugs can double risk of gastrointestinal bleeding 2Health News:Anti-depressant drugs can double risk of gastrointestinal bleeding 3
Silicone Foley Catheters 2-Way (Pediatric)...
Midstream Catch Kits...
Midstream Catch Kits...
... The Pediatric BladderScan® ... to Diagnostic Ultrasound's trusted ... By enabling healthcare providers ... bladder volume noninvasively, this ...
Medicine Products: